Form 8-K INVACARE CORP For: Nov 20
Tweet
Share
E-mailUNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of
The Securities Exchange Act of 1934
Date of report (Date of earliest event reported):
November 20, 2015
INVACARE CORPORATION
(Exact name of Registrant as specified in its charter)
Ohio | 001-15103 | 95-2680965 |
(State or other Jurisdiction of Incorporation or Organization) | (Commission File Number) | (I.R.S. Employer Identification Number) |
One Invacare Way, P.O. Box 4028, Elyria, Ohio 44036
(Address of principal executive offices, including zip code)
(440) 329-6000
(Registrant’s telephone number, including area code)
————————————————————————————————
(Former name, former address and former fiscal year, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
————————————————————————————————————
Item 5.02. | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers |
On November 20, 2015, the Board of Directors of Invacare Corporation (the “Company”) elected Marc M. Gibeley as a member of the Company’s Board of Directors, effective immediately, on the unanimous recommendation of the Nominating and Governance Committee of the Board of Directors. Mr. Gibeley has been elected to serve a term expiring at the Company’s 2016 Annual Meeting of Shareholders. Mr. Gibeley has been appointed to the Company’s Audit Committee, where he replaces Baiju R. Shah, who has ceased serving on the committee.
Mr. Gibeley, 51, serves as Head of Diabetes Care North America for Roche Holding AG, a role he has held since May 2011. At Roche, Mr. Gibeley is responsible for all aspects of Roche’s diabetes care business in the United States and Canada, including sales, marketing, finance, customer support and product launches for the company's blood glucose monitoring and insulin pump business. From 2008 through 2011, Mr. Gibeley served as the President and Chief Executive Officer of WaveRx, a venture-backed diabetic neuropathy medical device business. Prior to joining WaveRx, Mr. Gibeley worked for several consumer packaged goods companies, including Procter and Gamble, Gillette, Eastman Kodak and Kraft Foods. Mr. Gibeley graduated from the United States Naval Academy in 1987.
There is no arrangement or understanding between Mr. Gibeley and any other person pursuant to which Mr. Gibeley was elected as a director of the Company. Mr. Gibeley has not entered into any related party transactions with the Company that are required to be disclosed pursuant to Item 404(a) of Regulation S-K.
On November 20, 2015, the Company issued a press release announcing the election of Mr. Gibeley to the Board of Directors, which is attached as Exhibit 99.1 to this Form 8-K
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits. | |
Exhibit Number | Description of Exhibit |
99.1 | Press Release, dated November 20, 2015. |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
INVACARE CORPORATION | ||
(Registrant) | ||
Date: November 20, 2015 | By: | /s/ Anthony C. LaPlaca |
Name: | Anthony C. LaPlaca | |
Title: | Senior Vice President, General Counsel and Secretary | |
Exhibit Index
Exhibit Number | Description of Exhibit |
99.1 | Press Release, dated November 20, 2015. |
Exhibit 99.1 | ||
NEWS RELEASE | CONTACT: | Lara Mahoney |
440-329-6393 | ||
MARC GIBELEY JOINS INVACARE BOARD OF DIRECTORS
ELYRIA, Ohio--(November 20, 2015)--Invacare Corporation (NYSE: IVC) today announced the appointment of Marc M. Gibeley to its Board of Directors. Mr. Gibeley is the Head of Diabetes Care North America for Roche Holding AG, where he is responsible for all aspects of Roche’s diabetes care, including sales, marketing, finance, customer support and product launches for the company’s blood glucose monitoring and insulin pump business. He will bring broad cross-functional leadership experience from both medical device and consumer products companies to the Invacare Board.
“After a thorough search led by a nationally recognized firm, I am pleased to welcome Marc Gibeley to Invacare’s Board of Directors. Marc is the third new independent director to join our Board over the past year and half. His perspective from the medical device industry, as well as other markets that have undergone significant change, will be a good addition to our Board of Directors. He has a keen understanding of the population that we serve, the ongoing healthcare reform changes that impact our business, and the rise of consumerism in the medical device space,” said Matthew M. Monaghan, Chairman, President and Chief Executive Officer, Invacare Corporation.
Prior to his position at Roche, Mr. Gibeley served as President and Chief Executive Officer of WaveRx, a venture-backed diabetic neuropathy medical device business. At WaveRx, Mr. Gibeley led all aspects of the company, including research and development, clinical research, regulatory affairs, manufacturing and operations, market and commercial development, and finance. Prior to WaveRx, Mr. Gibeley held several roles of increasing responsibility with some of the world’s best known companies, including Procter and Gamble, Gillette, Eastman Kodak and Kraft Foods.
Mr. Gibeley is a former U.S. Naval Officer and graduate from the United States Naval Academy. He holds his M.B.A from the University of Chicago.
Invacare Corporation (NYSE: IVC), headquartered in Elyria, Ohio, is a global leader in the manufacture and distribution of innovative home and long-term care medical products that promote recovery and active lifestyles. The company has 4,700 associates and markets its products in approximately 100 countries around the world. For more information about the company and its products, visit Invacare’s website at www.invacare.com.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- NUU Introduces the All-New X10 5G: Fully Unlocked. Nationwide 5G. Exceptional Value.
- ComEd Restores Power to 99% of Customers Impacted by Aug. 11-12 Storms
- XRP Price Prediction Drowns at $1 While Pepeto Ignites a Wallet Stampede Toward
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
